Shuttle Pharmaceuticals Holdings, Inc. — Form D

Shuttle Pharmaceuticals Holdings, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-07. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Adam ChambersDirectorGAITHERSBURG, MD
Christopher CooperDirectorGAITHERSBURG, MD
Angel LirianoDirectorGAITHERSBURG, MD
Oleh NabytDirectorGaithersburg, MD
Sachin PathigodaDirectorGaithersburg, MD
George ScorsisDirectorGAITHERSBURG, MD
Christopher CooperExecutive OfficerGAITHERSBURG, MD
Mira JungExecutive OfficerGaithersburg, MD
Timothy LorberExecutive OfficerGaithersburg, MD
Tyvin RichExecutive OfficerGaithersburg, MD
Yuying LiangRelated PersonGAITHERSBURG, MD
Christopher CooperRelated PersonGAITHERSBURG, MD
Adam ChambersRelated PersonGAITHERSBURG, MD
Angel LirianoRelated PersonGAITHERSBURG, MD
George ScorsisRelated PersonGAITHERSBURG, MD
George ScorcisDirectorGaithersburg, MD
Steven RichardsDirectorGaithersburg, MD
Joseph TungDirectorGaithersburg, MD
Peter DritschiloDirectorGaithersburg, MD
Peter DritschiloExecutive OfficerGaithersburg, MD
Joshua SchaferDirectorGaithersburg, MD
Chris SenanayakeDirectorGaithersburg, MD
Michael Vander HoekExecutive OfficerGaithersburg, MD
Bette JacobsDirectorGaithersburg, MD
Anatoly DritschiloDirectorGaithersburg, MD

Other filings by this issuer (8)

FiledFormOfferingSold
2026-05-15D$10.0M$10.0M
2025-06-26D$4.3M$4.3M
2024-10-25D$1.3M$790K
2023-01-20D$4.0M$4.0M
2022-08-15D$500K$125K
2022-02-22D$2.0M$365K
2022-01-04D$500K$500K
2019-01-31D—$913K

More